Sarfe Pharms Drug Patent Portfolio
Sarfe Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Sarfe Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10154963 | Controlled-release formulations comprising Torsemide | 06 Oct, 2033 | Active |
Latest Legal Activities on Sarfe Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sarfe Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Surcharge for late Payment, Small Entity | 17 Aug, 2022 | US10154963 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 17 Aug, 2022 | US10154963 |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Aug, 2022 | US10154963 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Sep, 2021 | US10154963 |
|
Correspondence Address Change
Critical
| 15 Sep, 2021 | US10154963 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 18 Dec, 2018 | US10154963 |
|
Recordation of Patent Grant Mailed
Critical
| 18 Dec, 2018 | US10154963 |
|
Email Notification
Critical
| 29 Nov, 2018 | US10154963 |
|
Issue Notification Mailed
Critical
| 28 Nov, 2018 | US10154963 |
|
Application Is Considered Ready for Issue
Critical
| 14 Nov, 2018 | US10154963 |
| Dispatch to FDC | 14 Nov, 2018 | US10154963 |
|
Issue Fee Payment Received
Critical
| 13 Nov, 2018 | US10154963 |
|
Issue Fee Payment Verified
Critical
| 13 Nov, 2018 | US10154963 |
| Supplemental Papers - Oath or Declaration | 12 Nov, 2018 | US10154963 |
| Workflow - Drawings Finished | 29 Oct, 2018 | US10154963 |
Sarfe Pharms's Family Patents
Sarfe Pharms Drug List
Given below is the complete list of Sarfe Pharms's drugs and the patents protecting them.
1. Soaanz
Soaanz is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10154963 | Controlled-release formulations comprising Torsemide |
06 Oct, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Soaanz's drug page